Provectus 与国药-中国医药工业研究总院和 国药A-THINK Pharmaceuticals Co., Ltd.签署谅解备忘录
田纳西州诺克斯维尔 (美国商业资讯) — Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (http://www.pvct.com)是一家开发阶段肿瘤科和皮肤科生物制药公司(“Provectus”)。公司今天宣布已与国药-中国医药工业研究总院(国药-CSIPI,中国所有医药研究院中的领先者)和国药 A-THINK...
View ArticleNovaBay Announces Results of NVC-422 Phase 2 for Viral Conjunctivitis
EMERYVILLE, Calif. NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY) announced today that its NVC-422 ophthalmic formulation did not meet the primary or secondary endpoints in a Phase 2 clinical study in...
View ArticleQImaging Launches New Complete, Live Cell Imaging Solution
SURREY, Canada QImaging™ today launched a new, all-in-one camera package that supports demanding live cell fluorescence imaging requirements. The Live Cell Imaging Package provides researchers with...
View ArticleMood Lifts for Medtech in First Half of 2014 While Pharma Sector Faces New...
LONDON & BOSTON & TOKYO An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014 in the pharma and biotech sectors, but a slowdown in IPOs...
View ArticleProject Data Sphere, LLC任命Kald Abdallah博士为Project Data Sphere总监
北卡罗来纳州卡利 (美国商业资讯)–Project Data Sphere, LLC任命医学博士和哲学博士Kald Abdallah为Project Data Sphere总监,负责www.ProjectDataSphere.org数据共享平台的持续快速发展。该平台提供广泛的癌症研究数据库访问权限,促成前所未有的研究合作,以解决复杂的科学问题。 Project Data Sphere,...
View Article2014 International Symposium on Human Identification (ISHI) Celebrates 25...
MADISON, Wis. Twenty-five years ago, forensics was a very different field. Blood types were widely used as screening tools and DNA fingerprinting was in its infancy. Today, DNA forensics is part of...
View Article昆泰首席执行官将出席摩根士丹利全球医疗保健大会
北卡罗来纳州三角研究园 (美国商业资讯)–昆泰公司首席执行官Tom Pike将出席2014年9月8日周一在纽约君悦酒店(Grand Hyatt Hotel)举办的摩根士丹利全球医疗保健大会。 昆泰的演讲将于美国东部时间上午9:55开始。投资者可以访问昆泰的投资者关系网站www.quintiles.com/investors访问演讲的直播音频网播。存档的演讲音频版本将在当天稍晚时间发布。...
View ArticleクインタイルズのCEOがモルガン・スタンレー・グローバル・ヘルスケア会議で発表
米ノースカロライナ州リサーチ・トライアングル・パーク (ビジネスワイヤ) — クインタイルズのトム・パイク最高経営責任者(CEO)は、2014年9月8日(月)にニューヨークのグランドハイアット・ホテルで開催のモルガン・スタンレー・グローバル・ヘルスケア会議でプレゼンテーションを行います。...
View Article《临床肿瘤学杂志》发表口服REVLIMID联合标准R-CHOP治疗弥漫大B细胞淋巴瘤患者的临床研究结果,总缓解率达到98%,完全缓解率达到80%
新泽西州萨米特 (美国商业资讯) — Celgene Corporation (NASDAQ:CELG)今天宣布,一项评估REVLIMID®(来那度胺)联合利妥昔单抗、环磷酰胺、盐酸多柔比星、硫酸长春新碱和泼尼松(R-CHOP)用于初治弥漫大B细胞淋巴瘤 (DLBCL)的研究结果在《临床肿瘤学杂志》印刷版出版之前在线发表。 该研究为II期、开放、单组研究,研究者是梅奥诊所(Mayo...
View ArticleFortuneRock (China) Ltd. Announces Investments Totaling $24 Million
BEIJING FortuneRock (China) Ltd. is pleased to announce that it has received investments for its ongoing novel protein drug development and pre-IPO funding totaling $24m (RMB145m). About RMB120m is...
View ArticleAesyntTM Continues Worldwide Expansion in Thailand with Exclusive...
CRANBERRY TOWNSHIP, Pa. Aesynt™, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, announced a new strategic partnership for IV automation solutions in...
View ArticleArticle 1
米ニュージャージー州サミット (ビジネスワイヤ) — セルジーン・コーポレーション(NASDAQ:CELG)は本日、未治療のびまん性大細胞型B細胞性リンパ腫(DLBCL)患者を対象とするレブラミド(レナリドミド)とリツキシマブ、シクロホスファミド、ドキソルビシン塩酸塩、ビンクリスチン硫酸塩、プレドニゾン(R-CHOP)の併用療法を評価する試験の結果が、印刷版に先駆けてJournal of...
View ArticleBeigene Enrolls First Patient in Phase 1 Study of BGB-3111
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced that it has dosed the first patient in a Phase 1...
View Articleハートサインの新しいAEDは自動ショックの付与が可能
北アイルランド・ベルファスト、米ペンシルベニア州ニュータウン (ビジネスワイヤ) — ハートサイン・テクノロジーズは、当社の好評のsamaritan PAD 350Pをベースとした全自動AED(自動体外式除細動器)samaritan® PAD 360Pを発表します。 HeartSine samaritan PAD 360P Fully Automatic Public Access...
View Article新款HeartSine AED提供自动电击治疗
北爱尔兰贝尔法斯特和宾夕法尼亚州纽敦 (美国商业资讯) — HeartSine® Technologies荣幸地宣布,全自动AED(自动体外除颤器)samaritan® PAD 360P上市销售,这是该公司在广受欢迎的samaritan PAD 350P基础上开发的新产品。 HeartSine samaritan PAD 360P Fully Automatic Public Access...
View ArticleBrainlab: First Patient Treatment with Revolutionary New Radiosurgery...
MUNICH, Germany New Automatic Brain Metastases Planning* software by Brainlab has been clinically used to successfully deliver fast, efficient radiosurgery treatment to a patient with metastatic...
View ArticleNuGEN Introduces Target Enrichment Technology for Comprehensive Detection of...
SAN CARLOS, Calif. NuGEN Technologies, Inc., a market leader in the development of solutions for Next Generation Sequencing (NGS) applications, has announced the release of a novel targeted...
View ArticleBeiGene Expands Management Team with Two Strategic Senior Positions
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the additions of two senior members to the...
View ArticleWorld Economic Forum Selects Labcyte as 2015 Technology Pioneer
SUNNYVALE, Calif. Labcyte Inc., the company revolutionizing life science research with the Echo® acoustic liquid handler, was recognized by the World Economic Forum for demonstrating the ability to...
View Article